Literature DB >> 11511941

Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients.

J Garnacho-Montero1, J Madrazo-Osuna, J L García-Garmendia, C Ortiz-Leyba, F J Jiménez-Jiménez, A Barrero-Almodóvar, M C Garnacho-Montero, M R Moyano-Del-Estad.   

Abstract

OBJECTIVE: To determine risk factors and clinical consequences of critical illness polyneuropathy (CIP) evaluated by the impact on duration of mechanical ventilation, length of stay and mortality.
DESIGN: Inception cohort study.
SETTING: Intensive care unit of a tertiary hospital. PATIENTS: Septic patients with multiple organ dysfunction syndrome requiring mechanical ventilation and without previous history of polyneuropathy.
INTERVENTIONS: Patients underwent two scheduled electrophysiologic studies (EPS): on the 10th and 21st days after the onset of mechanical ventilation.
RESULTS: Eighty-two patients were enrolled, although nine of them were not analyzed. Forty-six of the 73 patients presented CIP on the first EPS and 4 other subjects were diagnosed with CIP on the second evaluation. The APACHE II scores of patients with and without CIP were similar on admission and on the day of the first EPS. However, days of mechanical ventilation [32.3 (21.1) versus 18.5 (5.8); p=0.002], length of ICU and hospital stay in patients discharged alive from the ICU as well as in-hospital mortality were greater in patients with CIP (42/50, 84% versus 13/23, 56.5%; p=0.01). After multivariate analysis, independent risk factors were hyperosmolality [odds ratio (OR) 4.8; 95% confidence intervals (95% CI) 1.05-24.38; p=0.046], parenteral nutrition (OR 5.11; 95% CI 1.14-22.88; p=0.02), use of neuromuscular blocking agents (OR 16.32; 95% CI 1.34-199; p=0.0008) and neurologic failure (GCS below 10) (OR 24.02; 95% CI 3.68-156.7; p<0.001), while patients with renal replacement therapy had a lower risk for CIP development (OR 0.02; 95% CI 0.05-0.15; p<0.001). By multivariate analysis, CIP (OR 7.11; 95% CI 1.54-32.75; p<0.007), age over 60 years (OR 9.07; 95% CI 2.02-40.68; p<0.002) and the worst renal SOFA (OR 2.18; 95% CI 1.27-3.74; p<0.002) were independent predictors of in-hospital mortality.
CONCLUSIONS: CIP is associated with increased duration of mechanical ventilation and in-hospital mortality. Hyperosmolality, parenteral nutrition, non-depolarizing neuromuscular blockers and neurologic failure can favor CIP development.

Entities:  

Mesh:

Year:  2001        PMID: 11511941     DOI: 10.1007/s001340101009

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  103 in total

Review 1.  Persistent systemic inflammation in chronic critical illness.

Authors:  Christopher E Cox
Journal:  Respir Care       Date:  2012-06       Impact factor: 2.258

2.  Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both?

Authors:  Nicola Latronico
Journal:  Intensive Care Med       Date:  2003-09       Impact factor: 17.440

3.  Neurally adjusted ventilatory assist in patients with critical illness-associated polyneuromyopathy.

Authors:  Daniel Tuchscherer; Werner J Z'graggen; Christina Passath; Jukka Takala; Christer Sinderby; Lukas Brander
Journal:  Intensive Care Med       Date:  2011-11-03       Impact factor: 17.440

4.  Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle.

Authors:  Jennifer L Steiner; Kristen T Crowell; Scot R Kimball; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

Review 5.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

6.  Neurally adjusted ventilatory assist improves patient-ventilator interaction.

Authors:  Lise Piquilloud; Laurence Vignaux; Emilie Bialais; Jean Roeseler; Thierry Sottiaux; Pierre-François Laterre; Philippe Jolliet; Didier Tassaux
Journal:  Intensive Care Med       Date:  2010-09-25       Impact factor: 17.440

Review 7.  [Cellular regulation of anabolism and catabolism in skeletal muscle during immobilisation, aging and critical illness].

Authors:  Eva-Maria Strasser; Barbara Wessner; Erich Roth
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 8.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

9.  Occurrence of neuropathies in patients with severe heart failure before and after heart transplantation.

Authors:  Sergio Bagnato; Chiara Minà; Antonino Sant'Angelo; Cristina Boccagni; Caterina Prestandrea; Alessandra Caronia; Francesco Clemenza; Giuseppe Galardi
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

10.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.